Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Accretion Nutraveda
Price Band
₹122.0–129.0
Issue Size
₹24.77 Cr
Lot Size
1,000 shares
Min Investment
₹258,000
GMP
+₹68.0 (52.71%)
Issue Price
₹129.0
calendar_month Important Dates
bar_chart Subscription Status
Subscription data unavailable
trending_up Grey Market Premium (GMP)
GMP
+₹68.0
GMP %
+52.71%
Est. Listing
₹197.0
schedule Updated: 14 Jul 2026 15:52
Share GMP:
business About the Company
Accretion Nutraveda is a manufacturer of Ayurvedic and nutraceutical formulations, offering a wide range of dosage forms such as tablets, capsules, syrups, powders, oils, and topical products, including balms, creams, and gels. The company functions as a Contract Development and Manufacturing Organization (CDMO), catering to both Indian and overseas clients. Its international footprint spans markets like Sri Lanka, Singapore, and the United States. By blending traditional Ayurvedic knowledge with contemporary nutraceutical research, Accretion Nutraveda develops products targeting key wellness areas such as liver health, women’s care, bone and joint support, brain health, and respiratory well-being. Business Verticals: Domestic Sales and Merchant Exports (Loan License Model): Accounted for approximately 96.62% of total revenue in FY 2024–25. Direct Exports: Contributed around 38% of revenue, reflecting steady and ongoing growth. The company operates a manufacturing unit in Gujarat with a built-up area of nearly 10,763 square feet. The facility is fitted with advanced infrastructure, including 13 air handling units, dedicated processing zones, and robust quality assurance systems. It holds multiple certifications such as GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, and Halal, and is also licensed by FSSAI, underscoring its strong compliance and quality standards.
payments Company Financials (₹ Cr)
As of 2025-09-30
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 16.35 | 10.86 | 4.64 | 4.06 |
| Total Income | 14.07 | 16.06 | 5.20 | 3.07 |
| Profit After Tax | 2.33 | 2.61 | 0.82 | 0.28 |
| EBITDA | 3.29 | 3.65 | 1.21 | 0.59 |
| NET Worth | 8.26 | 5.35 | 1.08 | 0.26 |
| Reserves and Surplus | 2.95 | 4.86 | 0.72 | -0.10 |
| Total Borrowing | 4.43 | 3.86 | 2.17 | 1.97 |
Key Ratios
EPS
₹4.91
NAV
₹14.72
ROE
81.22%
ROCE
36.98%
RoNW
48.85%
P/B Value
8.76
P/E Ratio
26.27
Market Cap
₹93.40 Cr
PAT Margin
16.33%
Debt/Equity
0.72
Promoters
Mayur Popatlal Sojitra, Ankurkumar Shantilal Patel, Paraskumar Vinubhai Parmar, Hardik Mukundbhai Prajapati, Harshad Nanubhai Rathod and Vivek Ashok Kumar Patel
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Purchase of Machineries for Automation in existing Manufacturing unit 4.22 2 Purchase of Machineries for New Manufacturing Setup 8.03 3 Funding working capital requirements of the Company 5.50 4 General Corporate Purposes 3.69 5 Issue Expenses 3.33 Total 24.77
info Issue Details
pie_chart Investor Allocation
Registrar
Lead Managers / Book Running
timeline IPO Timeline
Open
28 Jan 2026
Close
30 Jan 2026
Allotment
02 Feb 2026
Listing
04 Feb 2026